Resources_Banner

Archimedes News

Thu, 04/14/2011 - 02:45

Left Column Title:

Corporate News

Left Column Content:

May 3: HHS Contract

We announced that the U.S. Department of Health and Human Services has contracted with us to use ARCHeS in HHS agencies. More...

Mar 28: Quintiles Agreement

We announced an agreement with Quintiles where they will incorporate ARCHeS into their existing solutions and our customers with have access to Quintiles expertise. More...

Jan 19: IndiGO at Tulsa Health System

MyHealth Access Network, a Beacon Community in Oklahoma, is deploying our IndiGO platform. This is the third deployment of IndiGO in as many months. More...

Dec 8: ARCHeS upgrade and Model (validation) reports available

Upgrade of ARCHeS included numerous improvements to the healthcare processes as well as significant enhancements to the physiology model. Processing speed was increased and several intervention enhancements were made available. Model (validation) reports are now available for download

Dec 7: IndiGO at Colorado Beacon Consortium

We entered into an agreement with the Colorado Beacon Consortium (CBC) for the use of the Individualized Guidelines and Outcomes (IndiGO) platform. More...

Nov 17: IndiGO Program Underway at Fairview

We entered into an agreement with Minnesota’s Fairview Health Services for the use of the Individualized Guidelines and Outcomes (IndiGO) platform. More...

May 23: ARCHeS Innovator launched at ISPOR

We launched ARCHeS Innovator, giving health experts direct access to many of the features of the Archimedes Model. More...

May 19: Individualized Guidelines draws media attention

A ground-breaking publication on the use of individualized guidelines draws media attention from New York Times, Healthday, Medscape, Reuters, ModernHealthcare and many others.

March 24: Collaboration with Novo Nordisk announced

We announced our collaboration with NovoNordisk to evaluate the effects of standardized vascular health checks on expected health outcomes in Europe. More...

Jan 20: Collaboration with FDA announced

We announced our collaboration with the FDA to develop a computer model of clinical trials evaluating weight loss medications. More...

Right Column Title:

Visit us at these events

Right Column Content:

June 2-6, 2012
17th Annual ISPOR meeting (Washington)

Visit us at booth #3, or attend the panel discussion about pharmacoeconomic modeling and the road to primetime. Panel members: David Eddy (Archimedes), Jaime Caro (UBC), Theresa Mullin (FDA), Nevine Zariffa (AstraZeneca), and Janet Brock (CMS).